TB Alternative Assets’s Molecular Data Inc. American Depositary Shares MKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-749,797
Closed -$421K 49
2022
Q2
$421K Buy
749,797
+643,463
+605% +$927K 0.21% 33
2022
Q1
$319K Sell
106,334
-46,371
-30% -$130K 0.11% 37
2021
Q4
$499K Sell
152,705
-180,628
-54% -$834K 0.15% 29
2021
Q3
$1.76M Hold
333,333
0.41% 26
2021
Q2
$4.67M Hold
333,333
0.93% 24
2021
Q1
$5.4M Buy
+333,333
New +$6.22M 1.02% 25

Other funds holding MKD

TB Alternative Assets's MKD Position: Q3 2022 in Review

TB Alternative Assets sold out of Molecular Data Inc. American Depositary Shares (MKD) in Q3 2022, closing a stake of 749,797 shares — an estimated $421K sold.

TB Alternative Assets first reported a position in MKD in Q1 2021 and held it in 6 quarters. The position peaked at $5.4M in Q1 2021. 2 funds tracked by Wall St. Rank hold MKD as of Q3 2022.

  • TB Alternative Assets reported no remaining Molecular Data Inc. American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • TB Alternative Assets sold 749,797 Molecular Data Inc. American Depositary Shares shares in Q3 2022, an estimated $421K.
  • TB Alternative Assets first reported a position in Molecular Data Inc. American Depositary Shares in Q1 2021 and held it in 6 quarters.
  • TB Alternative Assets's Molecular Data Inc. American Depositary Shares position peaked at $5.4M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Molecular Data Inc. American Depositary Shares as of Q3 2022.

Based on TB Alternative Assets's 13F filing for Q3 2022, filed 14 Oct 2022.